Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Patient-Reported Outcomes Between Rimegepant and Triptan Users With Migraine in the United States

NCT06680206 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06680206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06680206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Patient-Reported Outcomes Between Rimegepant and Triptan Users With Migraine in the United States
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 10, 2024
Completion date
November 20, 2024
Enrollment
1,395 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine